Evidence map›Paper›PMID 35619860›Full record

ArticleCureus2022

Anti-hyperglycemic Medication Compliance: A Quality Assurance Project.

Rayan Mamoon, Md Y Mamoon, Debbie Hermanstyne, Issac Sachmechi

Abstract read
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rayan MamoonEndocrinology and Diabetes, Queens Hospital Center, Jamaica, USA.
Md Y MamoonInternal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York City, USA.
Debbie HermanstyneEndocrinology and Diabetes, Queens Hospital Center, Jamaica, USA.
Issac SachmechiEndocrinology and Diabetes, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York City, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to determine the prevalence of adherence among diabetes patients treated at Queens Hospital Center's Diabetes Clinic and to determine barriers preventing adherence, 50 patients were asked a series of questions regarding their medication intake. The majority of patients reported that they understood the self-management steps that were necessary in order to control their diabetes. However, 30% of the interviewed patients with type 1 or type 2 diabetes reported that they missed a dose of their diabetes medication on at least one day in the last month. Forgetting and lifestyle inconveniences were the two most frequently reported reasons for non-adherence. Side effects and problems with the pharmacy or insurance were also significant reasons for non-adherence. Adherence can potentially be increased by combining new forms of treatment and increasing educational reinforcement.

Indexed as

diabetes educational reinforcementdiabetes self-carediabetes treatmentinsulin regimenmedication adherence strategies

Identifiers

PMID35619860
PMCPMC9126438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.